Eden PACS
Higia., Inc. d/b/a Eden · Decision date Oct 21, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Eden PACS, a radiological image processing system, under 510(k) number K261788. The applicant is Higia., Inc. d/b/a Eden of Wilmington, Delaware, and the submission was received on 05/29/2026 with a decision date of 10/21/2026. The device falls under regulation number 892.2050, product code LLZ, in the Radiology specialty and review panel. SESE denotes 510(k) clearance, not premarket approval.
The record describes the summary as abbreviated, states that it was not reviewed by a third party, and lists no combination product status and no authorized predetermined change control plan. The page does not identify a predicate device, describe the specific components or software changes reviewed, or provide any clinical performance data; those details would require the underlying FDA documents rather than this database entry.
No efficacy, safety, or labeling conclusions are drawn here, and the absence of predicate and change details limits any assessment of what the clearance covers beyond the classification fields shown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261788
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Higia., Inc. d/b/a Eden
- Product code
- LLZ
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Image Processing, Radiological.
- Applicant
- Higia., Inc. d/b/a Eden
- Product code
- LLZ
- FDA device class
- 2
FDA decision timeline
K261788 received
Application receipt date recorded by FDA.
K261788 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LLZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
3D Anatomical ModelK262132 | The Jacobs Institute | 510(k) clearance | Nov 5, 2026 | FDA |
LiLi DICOM Viewer (LiLi )K260454 | Elevate Imaging, Inc. | 510(k) clearance | Nov 4, 2026 | FDA |
| Canon Medical Informatics, Inc. | 510(k) clearance | Oct 29, 2026 | FDA | |
MIM KineticIDK261763 | Mim Software, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
PV-iCurve ProK261531 | Perception Vision Medical Technology Co., Ltd. | 510(k) clearance | Oct 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Higia., Inc. d/b/a Eden
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Wilmington, DE
Sources and methodology
- Original FDA record: K261788
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


